| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 06/27/2001 | CN1300590A Use of coating as taste masking agent for oral preparation |
| 06/27/2001 | CN1067680C Synthesis of carbamino imidazole |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/26/2001 | US6252112 Process for the preparation of an enantiomer of a (1R, 4S) or (1S, 4R)-1-amino-4-(hydroxymethyl)-2-cyclopentene derivative |
| 06/26/2001 | US6252087 Complexing with a protein |
| 06/26/2001 | US6252083 Fungicides, insecticides, nematocides |
| 06/26/2001 | US6251960 Polymerizing unsaturated monomer and blowing agent |
| 06/26/2001 | US6251944 (vitronectin receptor) integrin antagonist, useful for treating angiogenesis, tumor growth, tumor metastasis, osteoporosis and humoral hypercalcemia of malignancy |
| 06/26/2001 | US6251939 Carbamate-based cationic lipids |
| 06/26/2001 | US6251929 Administering to a patient a hydantoin derivatives and salts as therapeutic and preventive agents for intractable vasculitis such as malignant rheumatoid arthritis(mra), periarteritis nodosa, wegener's granulomatosis etc. |
| 06/26/2001 | US6251924 Pharmaceutical composition |
| 06/21/2001 | WO2001044226A1 Serine protease inhibitors |
| 06/21/2001 | WO2001044225A1 Dinitrile intermediates for the synthesis of omapatrilat and methods for producing same |
| 06/21/2001 | WO2001044203A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | WO2001044202A1 Hydantoin intermediates for the synthesis of omapatrilat and methods for producing and using the same |
| 06/21/2001 | WO2001044201A1 Substituted imidazole neuropeptide y y5 receptor antagonists |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001044170A1 Adamantane derivatives |
| 06/21/2001 | US20010004525 Histamine measuring apparatus and a histamine measuring method |
| 06/21/2001 | US20010004524 Holding in a recess of a vessel an oocyte that expresses histamine receptors, measuring the potential of membrane of oocyte by electrodes, infusing a sample into a fine reacting tube having antigen immobilized to promote hitamine release |
| 06/21/2001 | CA2394570A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/20/2001 | EP0890176B1 Proton conductor in liquid form |
| 06/20/2001 | CN1300303A Enzyme inhibitors |
| 06/20/2001 | CN1300278A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1067381C New 4-imidazolidinone compound, process for its preparation and pharmaceutical compositions which contain it |
| 06/19/2001 | US6248901 Heterocyclic vinyl ethers |
| 06/19/2001 | US6248787 Reducing cachexia |
| 06/19/2001 | US6248775 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 06/19/2001 | US6248769 Phenyl-triazole compounds for PDE-IV inhibition |
| 06/19/2001 | US6248765 Imidazole derivatives as histamine receptor H3 (ANT) agonists |
| 06/19/2001 | CA2191129C Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin |
| 06/19/2001 | CA2125964C Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists |
| 06/14/2001 | WO2001042222A1 Polymorphic crystalline forms of celecoxib |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001042201A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
| 06/14/2001 | WO2001042199A1 Amidinophenylpyruvic acid derivative |
| 06/14/2001 | WO2001042194A1 Adamantane derivatives |
| 06/14/2001 | WO2001042173A2 Method for the preparation of enantiomerically enriched compounds |
| 06/14/2001 | WO2001041760A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001002340A3 Novel aminoindanes |
| 06/14/2001 | US20010003780 Retinoid antagonists and uses thereof |
| 06/14/2001 | CA2394236A1 Adamantane derivatives |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/13/2001 | EP1106602A1 Simulated moving bed chromatographic purification of amino acids |
| 06/13/2001 | EP1105449A1 Amphoteric derivatives of aliphatic polyamines with fatty acids, esters or triglycerides |
| 06/13/2001 | EP0656892B1 Herbicidal 2- (4-heterocyclic-phenoxymethyl)phenoxy]-alkanoates |
| 06/13/2001 | CN1299344A Novel urea derivatives |
| 06/13/2001 | CN1067059C Intermediate for preparing a pharmaceutically active compound |
| 06/13/2001 | CN1067058C High purity 1,3-dialkyl-2-imidazolidinone and prepn. method therefor |
| 06/13/2001 | CN1067057C Serotonin 5-HI1A and dopamin D2 receptor ligands |
| 06/12/2001 | US6245918 Preparation of a molten salt from trialkyloxonium anion and amine |
| 06/12/2001 | US6245917 Used as an anticonvulsant; can be administered intravenously; stable, nonhygroscopic, and water soluble |
| 06/12/2001 | US6245871 Group 8-10 transition metal olefin polymerization catalysts |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245810 Amino acid derivatives |
| 06/12/2001 | US6245790 Oxazole compounds useful as PGE2 agonists and antagonists |
| 06/12/2001 | US6245786 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 06/12/2001 | US6245520 Methods for introducing nucleic acids into mammalian cells using imidazolium lipids |
| 06/12/2001 | CA2080917C New pharmacologically active catechol derivatives |
| 06/07/2001 | WO2001040146A1 Process for preparing ambient temperature ionic liquids |
| 06/07/2001 | WO2001039763A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors |
| 06/07/2001 | WO2001039762A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system |
| 06/07/2001 | WO2001030749B1 Novel compounds |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | US20010003121 Adamantane derivatives such as 2,4-dichloro-N-(tricyclo(3.3.1.13,7)dec-1-methyl)-benzamide; administering to treat rheumatoid arthritis; immunosuppressant |
| 06/07/2001 | CA2696185A1 Use of taurolidine and derivatives thereof in the treatment of cancer by induction of apoptosis |
| 06/07/2001 | CA2393252A1 Use of methylol-containing compounds to treat tumors |
| 06/07/2001 | CA2392783A1 Process for preparing ambient temperature ionic liquids |
| 06/06/2001 | EP1104754A1 Novel sulfonyl derivatives |
| 06/06/2001 | EP1104407A1 Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors |
| 06/06/2001 | EP1104300A2 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 06/06/2001 | EP1104298A2 Heterocyclic thioesters or ketones for vision and memory disorders |
| 06/06/2001 | CN1298386A N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders |
| 06/06/2001 | CN1298299A Antibacterial agents |
| 06/06/2001 | CN1298290A Use of retinoic acid activity inhibitors to slow down hair loss |
| 06/06/2001 | CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242611 Phenylimidazolidines containing nitrooxy or carbonyloxy groups |
| 06/05/2001 | US6242609 Ammonium trihalide for halogenation of color couplers and silver halide emulsions |
| 06/05/2001 | US6242605 Aryloxy-alkyl-dialkylamines |
| 06/05/2001 | US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents |
| 06/05/2001 | US6242475 Pesticidal 1-polyarylpyrazoles |
| 06/05/2001 | US6242474 Aromatic ring derivatives |
| 06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
| 06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 06/05/2001 | CA2059647C Thiocylating reagents and intermediates, thiopeptides, and methods for preparing and using same |
| 05/31/2001 | WO2001038295A1 Sphingosine derivatives |
| 05/31/2001 | WO2001037826A1 Npyy5 antagonists |
| 05/31/2001 | WO2001009103A3 Imidazole antiproliferative agents |
| 05/31/2001 | WO2000075172A3 Factor viia inhibitors |
| 05/31/2001 | US20010002400 Administering an antifungal agent |
| 05/31/2001 | DE19949237A1 Vorstufenverbindung für Radiodiagnostika Precursor for diagnostic radiopharmaceuticals |
| 05/30/2001 | EP1103552A1 Benzothiepin derivatives, process for the preparation of the same and uses thereof |
| 05/30/2001 | EP1103549A1 Photoprotective cosmetic compositions containing aminoamidine derivatives and uses thereof |
| 05/30/2001 | EP1103543A1 Novel urea derivatives bearing nitrogenous aromatic heterocycles |
| 05/30/2001 | EP1103243A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p |